QSAR of conformationally flexible molecules: Comparative Molecular Field Analysis of protein-tyrosine kinase inhibitors

SummaryComparative Molecular Field Analysis (CoMFA) has been applied to a study of quantitative structureactivity relationships (QSAR) of conformationally flexible molecules. The relationship between three-dimensional structure and activity of 20 styrene derivatives which inhibit protein-tyrosine kinase was determined. A technique was developed that allows accurate prediction of the inhibitory activity of these molecules and identification in each case of the active conformation. The problem of multiple energetically acceptable conformations was approached in an iterative procedure. Use was made of the varying degrees of symmetry among the molecules. First, CoMFA QSAR models were developed using only those compounds that possess a symmetrical substituent pattern on the phenyl ring. These CoMFA models were then used to select the active conformers of the less symmetrical compounds in the set. Allowing multiple conformers for each compound in the dataset yielded higher crossvalidated r2 values and better predictivity of the QSAR models. Different probe atoms (C+, O−, neutral C) were explored, the O− probe atom exhibiting the highest selectivity in the conformer selection process.

[1]  Yvonne C. Martin,et al.  DIRECT PREDICTION OF LINEAR FREE ENERGY SUBSTITUENT EFFECTS FROM 3D STRUCTURES USING COMPARATIVE MOLECULAR FIELD ANALYSIS. I, ELECTRONIC EFFECTS OF SU BSTITUTED BENZOIC ACIDS , 1991 .

[2]  K F Koehler,et al.  Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site. , 1990, Journal of medicinal chemistry.

[3]  W. Press,et al.  Numerical Recipes: The Art of Scientific Computing , 1987 .

[4]  R. Cramer,et al.  Validation of the general purpose tripos 5.2 force field , 1989 .

[5]  D. E. Patterson,et al.  Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies , 1988 .

[6]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .

[7]  S. Wold,et al.  The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses , 1984 .

[8]  S. Kellie,et al.  Tyrosine kinase activities and neoplastic transformation. , 1990, Biochemical Society transactions.

[9]  F I Carroll,et al.  Synthesis, ligand binding, QSAR, and CoMFA study of 3 beta-(p-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters. , 1991, Journal of medicinal chemistry.

[10]  W. Greenlee,et al.  Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells. , 1989, Biochemistry.

[11]  A. Harris,et al.  The epidermal growth factor receptor and the prognosis of bladder cancer , 1990, Cancer.

[12]  S. Wold,et al.  Multivariate Data Analysis in Chemistry , 1984 .

[13]  N el Tayar,et al.  Toxication of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and analogs by monoamine oxidase. A structure-reactivity relationship study. , 1990, Biochemical pharmacology.

[14]  F I Carroll,et al.  Synthesis and ligand binding of cocaine isomers at the cocaine receptor. , 1991, Journal of medicinal chemistry.

[15]  K. Umezawa,et al.  Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus. , 1989, Journal of natural products.

[16]  C. Heldin,et al.  Subversion of growth regulatory pathways in malignant transformation. , 1987, Biochimica et biophysica acta.

[17]  Bruce R. Kowalski,et al.  Chemometrics, mathematics and statistics in chemistry , 1984 .

[18]  H Umezawa,et al.  Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus , 1986, Molecular and cellular biology.

[19]  Y. Martin,et al.  Direct prediction of dissociation constants (pKa's) of clonidine-like imidazolines, 2-substituted imidazoles, and 1-methyl-2-substituted-imidazoles from 3D structures using a comparative molecular field analysis (CoMFA) approach. , 1991, Journal of medicinal chemistry.

[20]  M Terada,et al.  Molecular aspects of growth control. An extended report on the first joint meeting of the AACR and the Japanese Cancer Association. , 1989, Cancer Research.

[21]  William J. Dunn,et al.  Theoretical calculations on 1,2-ethanediol. Gauche-trans equilibrium in gas-phase and aqueous solution , 1991 .

[22]  Glen Eugene Kellogg,et al.  HINT: A new method of empirical hydrophobic field calculation for CoMFA , 1991, J. Comput. Aided Mol. Des..

[23]  K Watanabe,et al.  Specific inhibitors of tyrosine-specific protein kinase, synthetic 4-hydroxycinnamamide derivatives. , 1987, Biochemical and biophysical research communications.

[24]  G D Diana,et al.  CoMFA analysis of the interactions of antipicornavirus compounds in the binding pocket of human rhinovirus-14. , 1992, Journal of medicinal chemistry.

[25]  T Takeuchi,et al.  Antitumor activity of erbstatin, a tyrosine protein kinase inhibitor. , 1987, Japanese journal of cancer research : Gann.

[26]  A. Levitzki,et al.  Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors , 1988, Science.

[27]  H Hanhijärvi,et al.  Comparative molecular field analysis of some clodronic acid esters. , 1991, Journal of medicinal chemistry.

[28]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[29]  K Watanabe,et al.  Specific inhibitors of tyrosine-specific protein kinase. I. Synthesis and inhibitory activities of alpha-cyanocinnamamides. , 1988, Chemical & pharmaceutical bulletin.

[30]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[31]  Ettore Novellino,et al.  Comparative Molecular Field Analysis on a Set of Muscarinic Agonists , 1991 .

[32]  A. Levitzki,et al.  Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. , 1989, Journal of medicinal chemistry.

[33]  G Poste,et al.  Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 2. , 1988, Journal of medicinal chemistry.

[34]  T Nakamura,et al.  Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer , 1990, Cancer.

[35]  T Takeuchi,et al.  Inhibition of tyrosine protein kinase by synthetic erbstatin analogs. , 1987, The Journal of antibiotics.